Rea, D W <br/><br/>
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2005 
 - 1123-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdi227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Area Under Curve<br/>Camptothecin--administration & dosage<br/>Capecitabine<br/>Cohort Studies<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged